Evaluation of risk factors for cytomegalovirus DNAemia after end of regular prophylaxis after heart transplantation

ConclusionOur data should raise awareness of CMV-DNAemia after the termination of regular prophylaxis, as this affects one in five HTx patients. Especially old recipients as well as D+/R − and D−/R+ serology share an elevated risk of late CMV-DNAemia. For these patients, prolongation, or repetition of CMV prophylaxis, including antiviral drugs and CMV immunoglobulins, may be considered.

Source: Immunity, Inflammation and Disease - November 17, 2023 Category: Allergy & Immunology Authors: Moritz Benjamin Immohr, Daniel Oehler, Freya Sophie Jenkins, Nikolas Kalampokas, Vincent Hendrik Hettlich, Dennis Sigetti, Fabian Vo ß, Hannan Dalyanoglu, Hug Aubin, Payam Akhyari, Artur Lichtenberg, Udo Boeken Tags: ORIGINAL ARTICLE Source Type: research